We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLF icon
1651
Acushnet Holdings
GOLF
$6.05B
$950K ﹤0.01%
+14,405
New +$933K
ATAT icon
1652
Atour Lifestyle Holdings
ATAT
$4.77B
$949K ﹤0.01%
52,903
+5,048
+11% +$92.6K
MRNA icon
1653
Moderna
MRNA
$22.1B
$948K ﹤0.01%
8,900
-68,000
-88% -$6.85M
BCSAW
1654
CALL
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$947K ﹤0.01%
85,247
IART icon
1655
Integra LifeSciences
IART
$1.54B
$947K ﹤0.01%
26,709
+15,322
+135% +$613K
CSIQ icon
1656
Canadian Solar
CSIQ
$927M
$941K ﹤0.01%
47,630
-46,577
-49% -$1M
WDS icon
1657
Woodside Energy
WDS
$42.1B
$939K ﹤0.01%
+47,010
New +$951K
RCM
1658
DELISTED
R1 RCM Inc. Common Stock
RCM
$937K ﹤0.01%
+72,716
New +$845K
TIMB icon
1659
TIM SA
TIMB
$9.45B
$937K ﹤0.01%
+52,765
New +$958K
ABEO icon
1660
Abeona Therapeutics
ABEO
$343M
$935K ﹤0.01%
128,903
+81,047
+169% +$514K
HTLD icon
1661
Heartland Express
HTLD
$1.04B
$934K ﹤0.01%
+78,252
New +$995K
BLMN icon
1662
Bloomin' Brands
BLMN
$736M
$928K ﹤0.01%
+32,365
New +$880K
IXN icon
1663
iShares Global Tech ETF
IXN
$8.1B
$924K ﹤0.01%
+12,347
New +$887K
HLF icon
1664
Herbalife
HLF
$1.3B
$923K ﹤0.01%
91,809
-125,438
-58% -$1.35M
IPAR icon
1665
Interparfums
IPAR
$4.09B
$918K ﹤0.01%
+6,531
New +$925K
PAX icon
1666
Patria Investments
PAX
$1.79B
$917K ﹤0.01%
+61,797
New +$906K
OTEX icon
1667
Open Text
OTEX
$6.02B
$917K ﹤0.01%
+23,610
New +$950K
DOO
1668
Bombardier Recreational Products
DOO
$4.58B
$913K ﹤0.01%
13,600
+9,904
+268% +$653K
CFFSW
1669
CALL
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$911K ﹤0.01%
83,598
VSXY
1670
Victoria's Secret
VSXY
$7.1B
$909K ﹤0.01%
46,900
-948,257
-95% -$23.3M
ACVA icon
1671
ACV Auctions
ACVA
$1.43B
$902K ﹤0.01%
+48,058
New +$753K
CCK icon
1672
Crown Holdings
CCK
$13.2B
$901K ﹤0.01%
11,366
-16,748
-60% -$1.37M
WMS icon
1673
Advanced Drainage Systems
WMS
$11.1B
$901K ﹤0.01%
5,229
+1,805
+53% +$272K
ABVEW
1674
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$901K ﹤0.01%
107,213
LLYVK icon
1675
Liberty Live Group Series C
LLYVK
$9.45B
$899K ﹤0.01%
20,521
+9,287
+83% +$355K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.